-
There are minimally invasive therapies for the treatment of tumors! Big Curry experts explore the frontiers of minimally invasive tumor therapy.
Time of Update: 2020-08-12
Zhang Fujun, director of the minimally invasive intervention department of Sun Yat-sen University Cancer Prevention and Control Center in the current particle implant treatment technology has been widely promoted in China, and carried out a lot of innovative research.
-
The Nobel Prize Summit teamed up with the Harvard Medical MGH Oncology Center to help China's Dingno Award.
Time of Update: 2020-08-12
The International Exchange Association of Nobel Laureates, co-sponsored by Nobel Committee on Medical Sciences and 1993 Nobel Prize-winning Medical Physiology laureate Sir Richard Roberts and 2009 Nob
-
New hope for cancer patients! The "second-generation PD-1" drug is about to enter China.
Time of Update: 2020-08-12
TGF-beta:PD-1/PDL1 mono-resistant resistance for cancer patients, PD-1/PDL1 inhibitors are the biggest breakthrough in the history of tumor immunotherapy, has been approved by the U.S. FDA for more than a dozen types of cancer, including non-small cell lung cancer, liver cancer and stomach cancer.
-
Beijing Tsinghua Changyu Hospital, to liver and bile pancreatic tumor patients comprehensive tracking management.
Time of Update: 2020-08-12
2017, Beijing Tsinghua Changxuan Hospital has set up the MDT Center for hepatobiliary pancreatic tumors, which brings together experts from departments such as hepatobiliary surgery, hepatology, oncology, imaging, radiotherapy, intervention, pathology, clinical medicine, etc., and is committed to developing a full-scale diagnosis and treatment program for patients with multidisciplinary participation, providing tailor-made precision medical services.
-
Say no to the tumor! PD-1 occupies the market high ground.
Time of Update: 2020-08-12
"PD-1 and PD-L1 antibody drugs produce anti-tumor effects by destroying the immune escape mechanism of tumor cells." Qin Yan, deputy director of oncology medicine at the Oncology Hospital of the Chinese Academy of Medical Sciences, said.
-
False invoices were reported in The Cancer Hospital of Gansu Province.
Time of Update: 2020-08-12
announced that, in response to the inspection found problems, the provincial finance department has issued a notice of rectification in accordance with the law, the provincial cancer hospital has been in accordance with the requirements of rectification.
-
The 10th National Gastric Cancer Conference and the 3rd Sunshine Great Wall Cancer Conference were held.
Time of Update: 2020-08-12
In his opening remarks, Professor Ji Jiafu, Chairman of the Professional Committee of Gastric Cancer of the China Anti-Cancer Association and President of Peking University Cancer Hospital, said in his opening remarks that the session continued the theme of "standardization, integration and innovation" with the aim of further improving the standardization of gastric cancer diagnosis and treatment in China, promoting multidisciplinary collaboration, promoting the development of translational medicine, and will make more useful attempts to strengthen international exchanges and cooperation.
-
The 2015 First Oncology Precision Medicine Forum was successfully held in Beijing.
Time of Update: 2020-08-12
to promote clinical research on pancreatic cancer treatment, the Scientific Anti-Cancer Promotion Committee of the China Life Care Association has established the "Special Fund for the Treatment of Pancreatic Cancer Relief Bank", which received the first batch of 1.3 million yuan from Baofa and others at the scene of the conference.
-
2019 China Oncology Congress held! 36 academicians and 30,000 oncology elites focused on the forefront.
Time of Update: 2020-08-12
(Health Times media group Ko Xiaoxuan Li Tianhao Li Hao Zhao Chunwei) "This conference is one of the largest, highest specifications and the most extensive coverage of the academic community in China,
-
The exact treatment of tumors is no worse than the cruise missile.
Time of Update: 2020-08-12
Professor Dong Baoxuan, the pioneer of microwave ablation in China and former director of the ultrasound department of the PLA General Hospital, told reporters that the first use of ultrasound, CT, nuclear magnetic imaging, doctors accurately grasp the shape of the tumor.
-
The release of data on the treatment of cancer electric field in Asia is expected to rewrite the clinical treatment of gliomas in China.
Time of Update: 2020-08-12
(Health Times reporter Ko Xiaoxuan) . Recently, at the 16th Annual Meeting of the Asian Conference on Neuro-Oncology (ASNO), the results of the global phase III critical clinical study EF-14 Asian pop
-
Cancer palliative care has a long way to go.
Time of Update: 2020-08-12
Vice President of the Medical Association Wang Tiecheng and Professor Wang Jiejun, Chairman of the Cancer Rehabilitation and Palliative Care Committee of the Chinese Association of Cancer Association, attended the conference and spoke.
-
Anjin's 19 billion yuan stake in Baiji Shenzhou will jointly develop 20 anti-tumor drugs in the future.
Time of Update: 2020-08-12
Health Times reporter Xu Weizhao the founder, chairman and chief executive officer of Baiji Shenzhou, chairman and chief executive officer, said that the cooperation between Baiji Shenzhou and Anjin is mainly two aspects, one is around Amgen's three approved mature tumor products Xgeva (dishumono), Kyprolis (Kafizomi) and dual antibody-specific drug Blincyto (Pirinto-) in China for commercialization for five years or seven years.
-
Tianjin: Binhai New Area Cancer Hospital will open and locate the Three A Specialist Hospital.
Time of Update: 2020-08-12
Binhai New Area Cancer Hospital is positioned as a tertiary A specialist hospital, with a total planned number of 1200 beds, of which 600 beds will be set up in the first phase of the project.
-
The diagnosis model of brain stem tumor has been a major breakthrough, and the research results fill the gaps in the field.
Time of Update: 2020-08-12
's team and Professor Bohai's team used the world's only gene panel, which covers almost all of the brain tumor development events (the term gene detection, which refers to genetic detection multiple sites) to sequence the free tumor DNA in the cerebrospinal fluid of brain stem glioma patients in depth.
-
A family of three brothers has been diagnosed with stomach cancer in succession! Oncologist: The culprit is in this eating habit.
Time of Update: 2020-08-12
(Health Times reporter Zhang He) . Huang Youchun, 65, of Taizhou City, Zhejiang Province, and two cousins, aged 58 and 45, were diagnosed with stomach cancer in July and were admitted to the same hosp
-
HIV, advanced fertility, gynecological tumors, listen to the gynecology and gynecology of the big curry to say.
Time of Update: 2020-08-12
Professor Ma Qingliang, deputy head of the pelvic floor of the Department of Obstetrics and Gynaecology of Shanghai Medical Association and director of obstetrics and gynecology at Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine, and other experts combine their rich clinical experience to share clinical novel techniques with you.
-
Johnson and Johnson's new anti-tumor drug, Yondelis, was approved at the end of six years.
Time of Update: 2020-08-12
recently announced that its anti-cancer drug Yondelis has been approved by the U.S. FDA for the treatment of soft tissue sarcoma.
2001, Johnson and Johnson obtained the drug from Zeltia, a Spanish pharmaceutical company, and began research on Yondelis's treatment of ovarian cancer.
-
Can a cell phone cause a brain tumor? The authoritative expert's answer came.
Time of Update: 2020-08-12
Editor's note: May 9 (Thursday) 14:30-15:30 pm, neurosurgery leader, Beijing Tiantan Hospital Vice President Zhang Wei as a guest "people's good doctor" client, for 100,000 netizens popular brain tumor knowledge, and answer a group of netizens' disease questions.
-
Itolizumab Treatment of Acute GVHD: Positive Results.
Time of Update: 2020-08-11
Equillium, a clinical-stage biotech company that is developing the research drug itolizumab for the treatment of severe autoimmune and inflammatory diseases, today released positive interim data from the Ib Open Label Clinical Trial (EQUATE Study).
in the first two dose groups of the Ib open label section, 71% of patients reached CR on the 29th day.
